Baricitinib has been investigated for its potential to reduce the HIV reservoir and chronic inflammation in people infected with HIV. Preclinical studies in humanized mice and non-human primates have …

Aug 19, 2024 · Baricitinib (brand name Olumiant) is used to treat rheumatoid arthritis, severe alopecia areata (hair loss), and COVID-19 in certain patients. These conditions may be caused by an …

Dec 1, 2025 · Baricitinib is used alone or together with other medicines (eg, methotrexate, DMARDs) to treat moderately to severely active rheumatoid arthritis in patients who have taken other medicines …

Baricitinib is a medication that treats rheumatoid arthritis, severe hair loss and COVID-19 by helping your immune system function.

Baricitinib is a disease-modifying antirheumatic drug (DMARD) approved by the FDA to control inflammation in rheumatoid arthritis, alopecia areata, and COVID-19 in adults.

Discover Olumiant® (baricitinib), a Janus kinase (JAK) inhibitor, and how Olumiant® works for moderate to severe active Rheumatoid Arthritis (RA).

Medscape - Rheumatoid arthritis and COVID-19 dosing for Olumiant (baricitinib), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation schedules,...

Baricitinib, also known as Olumiant, is used to treat rheumatoid arthritis. It's a type of drug known as a Janus kinase JAK inhibitor. It works by blocking the action of Janus kinase enzymes, which are …

Baricitinib is used alone or with other medications to treat rheumatoid arthritis (condition in which the body attacks its own joints causing pain, swelling, and loss of function) in adults who have not …

Jan 10, 2024 · This activity comprehensively reviews the indications, contraindications, mechanisms, adverse events, and other crucial aspects of baricitinib therapy within the clinical setting.